Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 18 years old
- You have been diagnosed with asthma according to the 2023 GINA diagnostic guidelines (confirm with trial site)
- You are willing to sign a consent form, follow the study plan, and attend follow-up appointments for 2 years
Who may not be able to join:
- You have a serious lung condition that causes significant damage to lung tissue, such as severe bronchiectasis or tuberculosis
- You have a severe disease affecting the lining around the lungs, or significant damage to the breastbone or ribs
- You have another serious medical condition in another part of the body that is not well controlled
- You have had chest or abdominal surgery in the past 3 months
- You have had eye surgery in the past 3 months
- You have a detached retina (a problem at the back of the eye)
- You have had a heart attack in the past 3 months
- You have been hospitalised for a heart condition in the past 3 months
- You are currently receiving treatment for tuberculosis
- You are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kewu Huang, M.D., Beijing Chao Yang Hospital
Phone: 8613141403749
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Asthma Control Test(ACT); Asthma Control Questionnaire(ACQ); Induced sputum analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.